SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is gaining significant community traction as supporters rally behind its vision of a global digital currency for the cannabis ecosystem. Proponents are highlighting the project's focus on organic culture and long-term infrastructure over short-term hype, with active discussions centering on the potential for cannabis-related policies to further elevate the asset.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as investors weigh an oversold technical setup against significant leadership turnover in its AI division and ongoing geopolitical volatility. While some market participants are capitalizing on the depressed price as a value entry, others are voicing frustration over a delayed earnings announcement and broader macro uncertainty.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending due to heightened geopolitical tensions in the Middle East, specifically following U.S. military strikes on Iran's Kharg Island, which have sparked intense debate about potential supply chain disruptions and the future of the Strait of Hormuz. Investors are actively discussing whether this conflict will result in a sustained energy shock or if the market has already over-priced the risks, with many debating the impact on global inflation and potential supply-side interventions.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently under scrutiny as reports of significant workforce reductions circulate, which the market is interpreting as a strategic move to reallocate capital toward intensive AI infrastructure investments. Investors remain divided, with many debating whether these efficiency measures will bolster long-term operating margins or if they signal deeper structural challenges regarding the company's aggressive AI spending and model development timeline.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is attracting significant community attention following the FDA's acceptance of the NDA for its lead ADHD candidate, CTx-1301, with a target action date set for late May 2026. Investors are actively discussing the stock's potential for a buyout or strategic partnership, while also tracking updates on pending U.S. patent applications that could serve as key near-term catalysts for price appreciation.

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Korro Bio Inc.

Korro Bio Inc

Korro Bio is experiencing significant market interest driven by an oversubscribed $85 million private placement, which has strengthened the company's liquidity position. The community is actively discussing the stock's potential for a short squeeze given the relatively small float and high institutional ownership, while some investors remain cautious about the company's history of volatility and clinical challenges.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore (SOC) is currently experiencing intense market volatility driven by a high-stakes standoff between the Trump administration's efforts to expedite domestic oil production under the Defense Production Act and ongoing legal challenges from California state authorities. The community is actively debating the stock's potential for a significant short squeeze against the backdrop of critical infrastructure milestones, though concerns over the company's financial burn rate and complex regulatory landscape continue to fuel skepticism among short sellers.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending following the announcement that it has received a full notice to proceed on a multi-billion dollar design-build contract to provide natural gas-fired power generation for Applied Digital's AI data center campuses. Investors and community members are actively discussing the deal as a major catalyst for the company's growth, with many focused on the significance of securing Siemens Energy as a partner and the potential for a long-term re-rating as the project shifts from pipeline potential to active execution.

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.

Stryker Corp.

Stryker (SYK) shares are seeing heightened volatility as the company navigates a major Microsoft-based systems disruption attributed to an Iran-linked cyberattack. While the community is actively debating the severity of the operational impact and potential HIPAA liability, some investors view the resulting price dip as an opportunity to initiate or add to long-term positions.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

Terns Pharmaceuticals is surging due to highly promising preliminary Phase 1 clinical data for its lead oncology asset, TERN-701, which has sparked massive institutional buying and triggered multiple analyst price target upgrades. The community is actively debating the stock's long-term valuation as a single-asset pipeline play, with many participants split between momentum-driven bullish sentiment and concerns regarding potential dilutive offerings and the inherent volatility of early-stage biotech.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
